Richard A Van Etten Molecular Oncology Research Institute Tufts University Biography Publications Institution JoVE Articles Richard A Van Etten has not added a biography. If you are Richard A Van Etten and would like to personalize this page please email our Author Liaison for assistance. Publications Essential Role for Stat5a/b in Myeloproliferative Neoplasms Induced by BCR-ABL1 and Jak2V617F in Mice Blood. Jan, 2012 | Pubmed ID: 22234689 Distinct Graft-versus-leukemic Stem Cell Effects of Early or Delayed Donor Leukocyte Infusions in a Mouse Chronic Myeloid Leukemia Model Blood. Jan, 2012 | Pubmed ID: 22072555 Targeting CXCR4 with Cell-penetrating Pepducins in Lymphoma and Lymphocytic Leukemia Blood. Dec, 2011 | Pubmed ID: 22186993 Comparison of MRNA and Lentiviral Based Transfection of Natural Killer Cells with Chimeric Antigen Receptors Recognizing Lymphoid Antigens Leukemia & Lymphoma. Dec, 2011 | Pubmed ID: 22023526 Chronic Myeloid Leukemia 2011: Successes, Challenges, and Strategies--proceedings of the 5th Annual BCR-ABL1 Positive and BCR-ABL1 Negative Myeloproliferative Neoplasms Workshop American Journal of Hematology. Sep, 2011 | Pubmed ID: 21850662 BCL6: a Novel Target for Therapy of Ph+ B Cell Acute Lymphoblastic Leukemia Cancer Cell. Jul, 2011 | Pubmed ID: 21741592 CDK6 Kinase Activity is Required for Thymocyte Development Blood. Jun, 2011 | Pubmed ID: 21508411 Conformational Control Inhibition of the BCR-ABL1 Tyrosine Kinase, Including the Gatekeeper T315I Mutant, by the Switch-control Inhibitor DCC-2036 Cancer Cell. Apr, 2011 | Pubmed ID: 21481795 Navigating the Road Toward Optimal Initial Therapy for Chronic Myeloid Leukemia Current Opinion in Hematology. Mar, 2011 | Pubmed ID: 21252655 The Ph-positive and Ph-negative Myeloproliferative Neoplasms: Some Topical Pre-clinical and Clinical Issues Haematologica. Apr, 2011 | Pubmed ID: 21242185 Targeting Autophagy Potentiates Tyrosine Kinase Inhibitor-induced Cell Death in Philadelphia Chromosome-positive Cells, Including Primary CML Stem Cells The Journal of Clinical Investigation. May, 2009 | Pubmed ID: 19363292 GCK is Essential to Systemic Inflammation and Pattern Recognition Receptor Signaling to JNK and P38 Proceedings of the National Academy of Sciences of the United States of America. Mar, 2009 | Pubmed ID: 19246396 Murine Retroviral Bone Marrow Transplantation Models for the Study of Human Myeloproliferative Disorders Current Protocols in Pharmacology / Editorial Board, S.J. Enna (editor-in-chief) ... [et Al.]. Dec, 2008 | Pubmed ID: 22294220 Suppression of E-protein Activity Interferes with the Development of BCR-ABL-mediated Myeloproliferative Disease Proceedings of the National Academy of Sciences of the United States of America. Sep, 2008 | Pubmed ID: 18725623 Peroxiredoxin1 Prevents Excessive Endothelial Activation and Early Atherosclerosis Circulation Research. Sep, 2008 | Pubmed ID: 18689572 Bedside to Bench: Interfering with Leukemic Stem Cells Nature Medicine. May, 2008 | Pubmed ID: 18463658 Right on Target: Eradicating Leukemic Stem Cells Trends in Molecular Medicine. Nov, 2007 | Pubmed ID: 17981087 Molecular Mechanisms of Cardiotoxicity of Tyrosine Kinase Inhibition Nature Reviews. Cancer. May, 2007 | Pubmed ID: 17457301 Oncogenic Signaling: New Insights and Controversies from Chronic Myeloid Leukemia The Journal of Experimental Medicine. Mar, 2007 | Pubmed ID: 17353369 Ubiquitous and Uniform in Vivo Fluorescence in ROSA26-EGFP BAC Transgenic Mice Genesis (New York, N.Y. : 2000). Feb, 2007 | Pubmed ID: 17269129 Molecular Pathogenesis and Therapy of Polycythemia Induced in Mice by JAK2 V617F PloS One. 2006 | Pubmed ID: 17183644 Requirement for CD44 in Homing and Engraftment of BCR-ABL-expressing Leukemic Stem Cells Nature Medicine. Oct, 2006 | Pubmed ID: 16998483 Cardiotoxicity of the Cancer Therapeutic Agent Imatinib Mesylate Nature Medicine. Aug, 2006 | Pubmed ID: 16862153 Tyrosine Kinases As Targets for Cancer Therapy The New England Journal of Medicine. Jul, 2005 | Pubmed ID: 16014887 Tyrosine 394 is Phosphorylated in Alzheimer's Paired Helical Filament Tau and in Fetal Tau with C-Abl As the Candidate Tyrosine Kinase The Journal of Neuroscience : the Official Journal of the Society for Neuroscience. Jul, 2005 | Pubmed ID: 16014719 JAKing Up Hematopoietic Proliferation Cancer Cell. Apr, 2005 | Pubmed ID: 15837617 Imatinib Mesylate Radiosensitizes Human Glioblastoma Cells Through Inhibition of Platelet-derived Growth Factor Receptor Blood Cells, Molecules & Diseases. Mar-Apr, 2005 | Pubmed ID: 15727903 Focus on Myeloproliferative Diseases and Myelodysplastic Syndromes Cancer Cell. Dec, 2004 | Pubmed ID: 15607959 Adoptive Immunotherapy of BCR-ABL-induced Chronic Myeloid Leukemia-like Myeloproliferative Disease in a Murine Model Blood. Dec, 2004 | Pubmed ID: 15308567 A Direct Binding Site for Grb2 Contributes to Transformation and Leukemogenesis by the Tel-Abl (ETV6-Abl) Tyrosine Kinase Molecular and Cellular Biology. Jun, 2004 | Pubmed ID: 15143164 Requirement of Src Kinases Lyn, Hck and Fgr for BCR-ABL1-induced B-lymphoblastic Leukemia but Not Chronic Myeloid Leukemia Nature Genetics. May, 2004 | Pubmed ID: 15098032 Distinct Stem Cell Myeloproliferative/T Lymphoma Syndromes Induced by ZNF198-FGFR1 and BCR-FGFR1 Fusion Genes from 8p11 Translocations Cancer Cell. Mar, 2004 | Pubmed ID: 15050920 Mechanisms of Transformation by the BCR-ABL Oncogene: New Perspectives in the Post-imatinib Era Leukemia Research. May, 2004 | Pubmed ID: 15036938 C-Abl Regulation: a Tail of Two Lipids Current Biology : CB. Aug, 2003 | Pubmed ID: 12906815 Essential Role for the Peroxiredoxin Prdx1 in Erythrocyte Antioxidant Defence and Tumour Suppression Nature. Jul, 2003 | Pubmed ID: 12891360 Autoinhibition of Bcr-Abl Through Its SH3 Domain Molecular Cell. Jul, 2003 | Pubmed ID: 12887890 Studying the Pathogenesis of BCR-ABL+ Leukemia in Mice Oncogene. Dec, 2002 | Pubmed ID: 12476310 Clinical Resistance to the Kinase Inhibitor STI-571 in Chronic Myeloid Leukemia by Mutation of Tyr-253 in the Abl Kinase Domain P-loop Proceedings of the National Academy of Sciences of the United States of America. Aug, 2002 | Pubmed ID: 12149456 Critical Role for Gab2 in Transformation by BCR/ABL Cancer Cell. Jun, 2002 | Pubmed ID: 12124177 Tyrosine Phosphorylation of Mdm2 by C-Abl: Implications for P53 Regulation The EMBO Journal. Jul, 2002 | Pubmed ID: 12110584 The Tel-Abl (ETV6-Abl) Tyrosine Kinase, Product of Complex (9;12) Translocations in Human Leukemia, Induces Distinct Myeloproliferative Disease in Mice Blood. Jun, 2002 | Pubmed ID: 12036890 A Murine Model of CML Blast Crisis Induced by Cooperation Between BCR/ABL and NUP98/HOXA9 Proceedings of the National Academy of Sciences of the United States of America. May, 2002 | Pubmed ID: 12032333 प्रतिकृति - दोषपूर्ण Retrovirus 293T कोशिकाओं के क्षणिक अभिकर्मक द्वारा उत्पादन L Cristina Gavrilescu1, Richard A Van Etten1 1Molecular Oncology Research Institute, Tufts University JoVE 550 Biologia
प्रतिकृति - दोषपूर्ण Retrovirus 293T कोशिकाओं के क्षणिक अभिकर्मक द्वारा उत्पादन L Cristina Gavrilescu1, Richard A Van Etten1 1Molecular Oncology Research Institute, Tufts University JoVE 550 Biologia